Puli Pharmaceutical Co., Ltd.: It won the bid for the tenth batch of national centralized drug procurement. According to Puli Pharmaceutical, on December 12, Puli Pharmaceutical's meglumine gadolinium tetate injection (trade name: Puli Yingxian) and Posaconazole injection (trade name: Puli Posa) both won the bid for the tenth batch of national centralized drug procurement.On the 13th, coking coal fell by 2.15%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract coking coal closed at 2501, up or down by -2.15%, with a turnover of 104,800 lots. The position data showed that the top 20 seats were clear, and the difference position was 15,553 lots. The total contract turnover of coking coal futures was 180,200 lots, an increase of 8,845 lots over the previous day. The first 20 seats in the contract held 163,200 lots, an increase of 4,563 lots over the previous day. The short positions in the top 20 seats of the contract were 194,300 lots, an increase of 5,926 lots over the previous day. (Sina Futures)Qinchuan Machine Tool: The company's machine tool business section can provide a variety of processing equipment for humanoid robot manufacturers. Qinchuan Machine Tool said on the interactive platform that the company's machine tool business section can provide a variety of processing equipment for humanoid robot manufacturers, such as gear grinder, planetary roller screw pair key processing equipment thread grinder, etc. The spare parts business section of the company has the foundation of R&D and manufacturing of planetary roller screw by-products. Now, it has gradually started small batch production and verified its application. In the future, according to the market demand, it will gradually improve the detection and processing means and build its capacity.
Jiangxi procuratorate prosecuted Gao Zhunhu's suspected bribery case according to law. Recently, Gao Zhunhu (deputy department level), former deputy secretary and vice chairman of Jingdezhen CPPCC in Jiangxi Province, was under the jurisdiction of Jiangxi Provincial People's Procuratorate, and Pingxiang Municipal People's Procuratorate filed a public prosecution with Pingxiang Intermediate People's Court according to law. The case is being further processed. At the stage of examination and prosecution, the procuratorate informed the defendant Gao Zhuhu of his litigation rights according to law, interrogated the defendant according to law and listened to the opinions of the defenders. The Pingxiang Municipal People's Procuratorate sued the accusation: the defendant Gao Zhuhu used to be the secretary, deputy secretary and director of the Party Working Committee of Jingdezhen Ceramic Industrial Park, the secretary of the Party Working Committee of Jingdezhen Central City Changnan Development Zone, the party secretary and chairman of Jingdezhen Urban Construction and Development Investment Co., Ltd., the party secretary and chairman of Jingdezhen Urban Construction Investment Group Co., Ltd., and the party working Committee secretary of Jingdezhen Changnan New District. Jingdezhen High-tech Industrial Development Zone, deputy secretary of the Party Working Committee, director of the management committee and other positions, seek benefits for others, illegally accept other people's property, the amount is particularly huge, and should be investigated for criminal responsibility for accepting bribes according to law.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.The Zhuhai earthquake did not meet the emergency response standard, so citizens need not worry too much. On December 13th, some Zhuhai citizens felt obvious vibration, and many people suspected that an earthquake had occurred. Some citizens felt the vibration during lunch break, and some people felt the building shaking in the office. On the afternoon of the 13th, the reporter called the Seismological Bureau of Guangdong Province, and the relevant staff responded that at about 1: 25 noon on December 13th, a magnitude 2.1 earthquake occurred in the urban area of Zhuhai, so citizens need not worry too much. Because the magnitude of the earthquake did not reach the preset emergency response standard, the relevant departments did not start the emergency response mechanism, so the earthquake quick report information was not released. The staff member said that the bureau is also concerned about the public's concern about the earthquake, and is currently conducting corresponding research and judgment, and will issue corresponding research and judgment opinions later. (Nanfang Daily)
CITIC Jiantou: It maintains the "Buy" rating of Orrit, and its product line continues to expand and enrich. According to the research report of CITIC Jiantou Securities, Orrit (605116.SH) is one of the leading companies in the field of characteristic APIs in China. In recent years, the company's product line has been continuously expanded and enriched, which has promoted the continuous growth of revenue. At the same time, the company actively laid out potential areas, and at the current point of time, we think that we can see the company's follow-up multiple catalysis: 1) The preparation business continues to be heavy: the market development of diqu progesterone tablets continues to advance, and the estradiol/estradiol-diqu progesterone composite packaging tablets have been declared for listing. It is expected that the continuous enrichment of new pipelines for the follow-up preparation business will promote the company's performance growth. 2) Smegrutide API: The construction of fermentation workshop and synthesis workshop has been completed, and the expansion and release of new capacity will promote the good growth of API business. 3) Small nucleic acid business: The 100 kg commercial production line landed in September, 2004, opening up the space for subsequent growth. Maintain the "buy" rating.Baiyun Airport: The passenger throughput in the first November increased by 21.16% year-on-year. Baiyun Airport (600004) released the November production and operation data express on the evening of December 13th, and Baiyun Airport took 43,637 flights (sorties) in November, up by 12.94% year-on-year. Passenger throughput was 6,504,400 person-times, up by 19.94% year-on-year; The cargo and mail throughput was 212,100 tons, a year-on-year increase of 5.68%. Baiyun Airport took off and landed 465,983 sorties from January to November, up 12.05% year-on-year; The passenger throughput was 69.6674 million person-times, up by 21.16% year-on-year; The cargo and mail throughput was 2,161,300 tons, up 18.12% year-on-year.According to the local government, Russia attacked the energy facilities in the Lviv region in western Ukraine.
Strategy guide
12-14
Strategy guide 12-14